Showing results (101-110 of 237) with videos related to

Sort By:
Pageof 24
Blood|October 25, 2003
Early prediction of response in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL) treated with imatinibBarbara Wassmann, Heike Pfeifer, Urban J Scheuring, et al.
Cancer|November 24, 2020
Efficacy of inotuzumab ozogamicin in patients with Philadelphia chromosome-positive relapsed/refractory acute lymphoblastic leukemiaWendy Stock, Giovanni Martinelli, Matthias Stelljes, et al.
Leukemia & Lymphoma|October 12, 2020
Evaluation of six different types of sequential conditioning regimens for allogeneic stem cell transplantation in relapsed/refractory acute myelogenous leukemia - a study of the Acute Leukemia Working Party of the EBMTThomas Heinicke, Myriam Labopin, Emmanuelle Polge, et al.
Haematologica|July 30, 2016
Ciprofloxacin versus colistin prophylaxis during neutropenia in acute myeloid leukemia: two parallel patient cohorts treated in a single centerMichele Pohlen, Julia Marx, Alexander Mellmann, et al.
Transplantation and Cellular Therapy|September 14, 2023
Long-Term Survivors after Failure of Chimeric Antigen Receptor T Cell Therapy for Large B Cell Lymphoma: A Role for Allogeneic Hematopoietic Cell Transplantation? A German Lymphoma Alliance and German Registry for Stem Cell Transplantation AnalysisPatrick Derigs, Wolfgang A Bethge, Isabelle Krämer, et al.
Blood Cancer Journal|March 15, 2024
PTCy versus ATG as graft-versus-host disease prophylaxis in mismatched unrelated stem cell transplantationOlaf Penack, Mouad Abouqateb, Christophe Peczynski, et al.
Bone Marrow Transplantation|February 21, 2024
Fludarabine-treosulfan versus fludarabine-melphalan or busulfan-cyclophosphamide conditioning in older AML or MDS patients - A clinical trial to registry data comparisonDietrich Wilhelm Beelen, Simona Iacobelli, Linda Koster, et al.
Blood|July 1, 2011
High single-drug activity of nelarabine in relapsed T-lymphoblastic leukemia/lymphoma offers curative option with subsequent stem cell transplantationNicola Gökbuget, Nadezda Basara, Herrad Baurmann, et al.
Bone Marrow Transplantation|March 31, 2023
Fludarabine/TBI 8 Gy versus fludarabine/treosulfan conditioning in patients with AML in first complete remission: a study from the Acute Leukemia Working Party of the EBMTGesine Bug, Myriam Labopin, Riitta Niittyvuopio, et al.
Blood|May 18, 2012
Immunopharmacologic response of patients with B-lineage acute lymphoblastic leukemia to continuous infusion of T cell-engaging CD19/CD3-bispecific BiTE antibody blinatumomabMatthias Klinger, Christian Brandl, Gerhard Zugmaier, et al.
Pageof 24